We are committed to finding a safe and effective therapy for food and pediatric allergy patients

 

Living with Peanut Allergy: Learn More

Latest News

DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients

DBV Technologies Announces Publication of Positive Data from Phase IIb Trial and Long-Term Study of Viaskin Peanut inthe Journal of the American Medical Association

Documentation

20F- Form 2016

Agenda

Citi’s 2017 Global Healthcare Conference

New York, NY, USA